Related Experiment Video
Updated: Aug 24, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Rash associated with piperacillin/tazobactam administration in infectious mononucleosis
Aimée C LeClaire1, Craig A Martin, Ardis D Hoven
1Pharmacy Services, Chandler Medical Center, University of Kentucky, 800 Rose Street, Lexington, KY 40536-0293, USA.
Objective:
To report a case of piperacillin/tazobactam-induced rash in a patient with infectious mononucleosis.
Case Summary:
A 25-year-old white man developed a rash while receiving piperacillin/tazobactam 3.375 g intravenously every 6 hours and gentamicin for osteomyelitis complicating a left femur fracture secondary to a motorcycle accident. Due to progression of the rash following additional doses of piperacillin/tazobactam during hospitalization, the patient's antimicrobial regimen was changed to vancomycin and meropenem. Subsequently, a mononucleosis spot test was positive, and both Epstein-Barr virus (EBV) immunoglobulin (Ig) G and IgM antibodies were positive. The rash rapidly resolved with the discontinuation of piperacillin/tazobactam.
Discussion:
Although the development of rash following the administration of several different antimicrobials, especially ampicillin, has been previously reported, this is the first report of piperacillin/tazobactam-induced rash in infectious mononucleosis. The rash is generally self-limiting and usually resolves within days of discontinuing the causative antimicrobial agent. An altered drug metabolism or an immune-mediated process has been suggested as the potential mechanism for rash development.
Conclusions:
Prior reports of antimicrobial-induced rash in infectious mononucleosis and a positive laboratory diagnosis of EBV in our patient with no history of penicillin allergy support the identification of piperacillin/tazobactam as the inducer of the rash. According to the Naranjo probability scale, the association of piperacillin/tazobactam with the rash was classified as probable.
Insights
This case report details a piperacillin/tazobactam-induced rash in a patient with infectious mononucleosis. The rash resolved after discontinuing the antibiotic, highlighting a potential adverse drug reaction in EBV-positive patients.
Area of Science:
- Infectious Diseases
- Pharmacology
- Dermatology
Background:
- Infectious mononucleosis, caused by Epstein-Barr virus (EBV), can present with various symptoms.
- Antibiotic-induced rashes are a known complication of antimicrobial therapy.
- Piperacillin/tazobactam is a commonly used broad-spectrum antibiotic.
Observation:
- A 25-year-old male developed a progressive rash while on intravenous piperacillin/tazobactam and gentamicin for osteomyelitis.
- The rash resolved rapidly upon discontinuation of piperacillin/tazobactam.
- The patient was subsequently diagnosed with infectious mononucleosis, confirmed by positive EBV serology.
Findings:
- This is the first reported case of a piperacillin/tazobactam-induced rash in a patient with infectious mononucleosis.
- The Naranjo probability scale classified the association between piperacillin/tazobactam and the rash as probable.
- The rash is likely self-limiting and resolves after the causative agent is removed.
Implications:
- Clinicians should consider piperacillin/tazobactam as a potential cause of rash in patients with infectious mononucleosis, especially in the absence of penicillin allergy.
- Further investigation into the mechanisms of drug-induced hypersensitivity in EBV-infected individuals may be warranted.
- This case underscores the importance of careful medication review and adverse event monitoring in clinical practice.
Related Concept Videos
Chickenpox
Rocky Mountain Spotted Fever
Acute Pyelonephritis I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atypical Pneumonia